NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 908 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $576,000 | -13.8% | 6,900 | -23.3% | 0.00% | 0.0% |
Q1 2017 | $668,000 | +1.8% | 9,000 | 0.0% | 0.00% | -33.3% |
Q4 2016 | $656,000 | -4.5% | 9,000 | +3.4% | 0.00% | +50.0% |
Q3 2016 | $687,000 | -13.3% | 8,700 | -9.4% | 0.00% | -33.3% |
Q2 2016 | $792,000 | +14.0% | 9,600 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $695,000 | -15.6% | 9,600 | +7.9% | 0.00% | 0.0% |
Q4 2015 | $823,000 | +0.6% | 8,900 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $818,000 | -6.5% | 8,900 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $875,000 | +13.8% | 8,900 | +14.1% | 0.00% | +50.0% |
Q1 2015 | $769,000 | +6.4% | 7,800 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $723,000 | -1.5% | 7,800 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $734,000 | -6.9% | 7,800 | -10.3% | 0.00% | 0.0% |
Q2 2014 | $788,000 | +6.5% | 8,700 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $740,000 | +5.9% | 8,700 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $699,000 | +4.8% | 8,700 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $667,000 | +8.5% | 8,700 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $615,000 | – | 8,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |